Table 7.
Pulmonary arterial hypertension |
Idiopathic pulmonary arterial hypertension |
Familial pulmonary arterial hypertension |
BMPR2 gene mutation-associated, other |
Associated with systemic disease |
Congenital systemic to pulmonary shunts |
Congenital heart disease with Eisenmenger's syndrome. Examples: atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent ductus arteriosus, other |
Systemic arteriovenous shunt (vein of Galen malformation) |
Portal (portopulmonary) hypertension |
Collagen vascular disease |
Human immunodeficiency virus infection |
Drugs and toxins |
Other systemic disease |
Sickle cell disease/hemoglobinopathies |
Metabolic storage diseases (glycogen storage disease, Gaucher's disease, other) |
Hereditary hemorrhagic telangiectasia |
Langerhans cell histiocytosis |
Myeloproliferative disorders |
Splenectomy |
Associated with significant intrapulmonary venous or capillary involvement: |
Alveolar capillary dysplasia with misalignment of pulmonary veins |
Pulmonary veno-occlusive disease |
Pulmonary capillary hemangiomatosis |
Pulmonary venous hypertension |
Pulmonary vein obstruction |
Pulmonary vein stenosis |
Anomalous pulmonary venous connection with obstructive physiology |
Left atrial or ventricular disease heart disease |
Cardiomyopathy |
Other left ventricular failure |
Left-sided valvular heart disease |
Mitral stenosis |
Aortic stenosis |
Pulmonary arterial hypertension associated with hypoxemia |
Persistent pulmonary hypertension of the newborn |
Alveolar growth abnormalities (prematurity, hypoplasia, other) |
Interstitial lung disease |
Chronic obstructive pulmonary disease (cystic fibrosis, other) |
Other |
Sleep-disordered breathing |
Alveolar hypoventilation disorders |
Chronic exposure to high altitude |
Pulmonary hypertension due to chronic thrombotic and/or embolic disease |
Pulmonary arterial thromboembolism, proximal or distal |
Other embolism |
Examples: tumor, parasites, foreign material/intravenous drug abuse |
Miscellaneous |
Mediastinal/hilar pulmonary vascular compression, lymphangiomatosis, sarcoidosis |
Modified from 2003 revised World Health Organization classification of pulmonary hypertension, Proceedings of the 3rd World Symposium on Pulmonary Arterial Hypertension, Venice, Italy, June 23–25, 2003. J Am Coll Cardiol 2004; 43(Suppl. 12):1S–90S.